MedTrace Logo

Evaluating a Messaging Campaign in the United States

NCT04562636 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1244

Last updated 2020-10-05

No results posted yet for this study

Summary

Purpose: To evaluate reactions to and opinions of a messaging campaign.

Participants: Participants will be recruited through Prime Panels and will be US-based adults (18 years old and older) who consumed red meat in the past 30 days.

Procedures (methods): After completing a screening question about meat consumption, participants will review a consent form. If they select to participate in the study, participants will be randomly assigned to view control messages, red meat-related environment messages, or red meat-related health messages. They will be asked a series of questions about these messages.

Participants will also be asked about grocery shopping preferences and standard demographics questions.

Conditions

Interventions

OTHER

Environmental message

Participants will be randomized to view a set of four messages about the environmental harms of meat production from the Meatless Monday campaign.

OTHER

Health message

Participants will be randomized to view a set of four messages about the health harms of meat consumption from the Meatless Monday campaign.

OTHER

Neutral Message

Participants will be randomized to view a set of four messages about checking their credit score.

Sponsors & Collaborators

  • Wellcome Trust

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Hannah Rayala · University of North Carolina, Chapel Hill

  • Lindsey Smith Taillie, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-29
Primary Completion
2020-10-01
Completion
2020-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04562636 on ClinicalTrials.gov